NasdaqCM - Nasdaq Real Time Price USD

Bright Minds Biosciences Inc. (DRUG)

32.49
+0.43
+(1.34%)
At close: May 9 at 4:00:01 PM EDT
33.20
+0.71
+(2.19%)
After hours: May 9 at 7:37:50 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
2,748.42
2,822.77
7,386.41
14,975.09
8,786.20
Operating Income
-2,748.42
-2,822.77
-7,386.41
-14,975.09
-8,786.20
Net Non Operating Interest Income Expense
34.45
30.13
0
0
-18.67
Other Income Expense
1,645.90
-9.31
14.19
10.15
154.10
Pretax Income
-1,068.07
-2,801.95
-7,372.23
-14,964.94
-8,650.76
Net Income Common Stockholders
-1,068.07
-2,801.95
-7,372.23
-14,964.94
-8,650.76
Diluted NI Available to Com Stockholders
-1,068.07
-2,801.95
-7,372.23
-14,964.94
-8,650.76
Basic EPS
-0.20
-0.65
-1.98
-6.06
-4.82
Diluted EPS
-0.20
-0.65
-1.98
-6.06
-4.82
Basic Average Shares
4,890.94
4,310.17
3,719.78
2,470.38
1,794.81
Diluted Average Shares
5,009.92
4,310.17
3,719.78
2,470.38
1,794.81
Total Expenses
2,748.42
2,822.77
7,386.41
14,975.09
8,786.20
Net Income from Continuing & Discontinued Operation
-1,068.07
-2,801.95
-7,372.23
-14,964.94
-8,650.76
Normalized Income
-2,713.97
-2,792.63
-7,386.41
-14,975.09
-8,804.86
Interest Income
34.45
30.13
0
0
--
Net Interest Income
34.45
30.13
0
0
-18.67
EBIT
-2,748.42
-2,822.77
-7,386.41
-14,975.09
-8,786.20
EBITDA
-2,671.64
-2,749.41
-7,313.96
-14,969.06
-8,786.20
Reconciled Depreciation
76.78
73.36
72.45
6.04
0
Net Income from Continuing Operation Net Minority Interest
-1,068.07
-2,801.95
-7,372.23
-14,964.94
-8,650.76
Total Unusual Items Excluding Goodwill
1,645.90
-9.31
14.19
10.15
154.10
Total Unusual Items
1,645.90
-9.31
14.19
10.15
154.10
Normalized EBITDA
-4,317.54
-2,740.10
-7,328.15
-14,979.21
-8,940.30
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
9/30/2021 - 3/22/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MNPR Monopar Therapeutics Inc.
39.42
-6.96%
 
TVGN Tevogen Bio Holdings Inc.
1.0900
0.00%
 
BIVI BioVie Inc.
1.1200
-8.94%
 
TPST Tempest Therapeutics, Inc.
6.49
-5.26%
 
CADL Candel Therapeutics, Inc.
4.8100
+1.05%
 
DWTX Dogwood Therapeutics, Inc.
4.5600
0.00%
 
CAMP CAMP4 THERAPEUTICS CORPORATION
2.1300
-0.47%
 
QNRX Quoin Pharmaceuticals, Ltd.
6.19
-3.43%
 
SPRC SciSparc Ltd.
0.3443
+0.53%
 
TNXP Tonix Pharmaceuticals Holding Corp.
18.83
-0.58%